Plasma levels of insulin-like growth factor binding protein-4 (IGFBP-4) under normal and pathological conditions

Clinical Endocrinology

Volumn 54, Issue 5, 2001, Pages 655-664

  Van Doorn, J ^a   Cornelissen, A J F H ^a   Van Buul Offers, S C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; PARATHYROID HORMONE; POLYCLONAL ANTIBODY; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; SYNTHETIC PEPTIDE;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; AMNION FLUID; ARTICLE; BLOOD SAMPLING; CHILD; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIALYSIS; ENDOCRINE DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; GROWTH RETARDATION; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; HYPOTHYROIDISM; KIDNEY TRANSPLANTATION; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SOLID TUMOR; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGING; AMNIOTIC FLUID; BODY FLUIDS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLICULAR FLUID; GLUCOCORTICOIDS; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LINEAR MODELS; MALE; MIDDLE AGED; MILK, HUMAN; NEOPLASMS; RADIOIMMUNOASSAY; THYROID DISEASES;

EID: 0035724123     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01248.x     Document Type: Article

References (40)

1. Expression and downregulation by retinoic acid of IGF binding protein-2 and -4 in medium from human neuroblastoma cells
2. Studies on human pregnancy-induced insulin-like growth factor (IGF) -binding protein-4 proteases in serum: Determination of IGF-II dependency and localization of cleavage site
3. Glucocorticoid regulation of an insulin-like growth factor- binding protein-4 protease produced by a rat neuronal cell line
4. Proteolysis of insulin-like growth factor binding protein-5 by pregnancy serum and amniotic fluid
5. The LMS method for constructing normalized growth standards
6. Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A
7. The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumour-associated hypoglycaemia
8. General overgrowth in the fragile X syndrome: Variability in the phenotypic expression of the FMR1 gene mutation
9. Isolation of a somatomedin-binding protein from preterm amniotic fluid. Development of a radioimmunoassay
10. The insulin-like growth factor-binding protein-4 (IGFBP-4) -IGFBP-4 protease system in normal human osteoblast-like cells: Regulation by transforming growth factor-Beta
11. Elevated insulin-like growth factor (IGF) binding protein (IGFBP) -2 and IGFBP-4 expression of leukemic T-cells is affected by autocrine/paracrine IGF-II action but not by IGF type I receptor expression
12. 24 Hours plasma GH profiles, urinary GH excretion and plasma IGF-I and lI levels in prepubertal children with chronic renal insufficiency and severe growth retardation
13. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant
14. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure
15. Recombinant synthesis of insulin-like growth factor-binding protein-4 (IGFBP-4): Development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids
16. Physiological role of insulin-like-growth-factor-binding protein- 4 in human folliculogenesis
17. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
18. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
19. Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells
20. Inhibitory insulin-like growth factor-binding protein: Cloning, complete sequence, and physiological regulation
21. Insulin-like growth factor binding proteins in bone cell regulation
22. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells
23. Serum levels of insulin-like growth factor-I-II and insulin- like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia
24. Human leukemic T and B lymphoblasts produce insulin-like growth factor binding proteins 2 and 4
25. Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: A report of the southwest pediatric nephrology study group
26. Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure: A report of the southwest pediatric nephrology study group
27. Insulin-like growth factor binding proteins as growth inhibitors in children with chronic renal failure
28. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells
29. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
30. Plasma levels of insulin-like growth factor (IGF) -I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency
31. The 24/25-kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures
32. 1,25-Dihydroxyvitamin D3 increases secretion of insulin-like growth factor binding protein-4 (IGFBP-4) by human osteoblast- like cells in vitro and elevates IGFBP-4 serum levels in vivo
33. Serum levels of insulin-like growth factor binding proteins (IGFBP) -4 and -5 correlate with bone mineral density in
34. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice
35. Circulating levels of human insulin-like growth factor binding protein-6 (IGFBP-6) in health and disease as determined by radioimmunoassay
36. Evaluation of IGF system component levels and mitogenic activity of uremic serum on normal human osteoblasts
37. Molecular cloning of IGFBP-5 from SCLC cell lines and expression of IGFBP-4, IGFBP-5 and IGFBP-6 in lung cancer cell lines and primary tumours
38. The role of the insulin-like growth factor system in human cancer
39. Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation
40. Physiological role of the insulin-like growth factor binding proteins